Amiodarone Maintenance Dose
For oral maintenance therapy, the standard dose is 200–400 mg daily after completion of loading, with 200 mg daily preferred to minimize long-term toxicity. 1
Oral Maintenance Dosing
The lowest effective maintenance dose—ideally 200–300 mg daily—should be used whenever possible to reduce the risk of serious adverse effects, particularly pulmonary toxicity. 1
- After achieving a total loading dose of approximately 10 grams (typically 800–1,600 mg daily for ventricular arrhythmias or 600–800 mg daily for atrial fibrillation until 10 g accumulated), transition to maintenance therapy 1
- Standard maintenance: 200–400 mg once daily 1
- Preferred maintenance for atrial fibrillation: 200 mg daily 1
- Preferred maintenance for ventricular arrhythmias: 200–400 mg daily 1
The evidence strongly supports dose minimization: pulmonary toxicity occurs in 1–17% of patients historically, but incidence is substantially lower at doses ≤300 mg/day 1. Meta-analysis data confirm that even "low-dose" amiodarone (mean 152–330 mg daily) carries significantly higher odds of thyroid (OR 4.2), neurologic (OR 2.0), skin (OR 2.5), and ocular (OR 3.4) adverse effects compared to placebo 2.
Intravenous Maintenance Dosing
- After the first 24 hours of IV therapy: 0.5 mg/min (720 mg/24 hours) as a continuous infusion 3
- This maintenance infusion rate can be cautiously continued for 2–3 weeks regardless of age, renal function, or left ventricular function 3
- The infusion rate may be increased to achieve effective arrhythmia suppression, but mean daily doses above 2,100 mg are associated with increased risk of hypotension 3
Transition from IV to Oral Therapy
When switching from intravenous to oral amiodarone, the oral dose depends on the duration of IV therapy: 4
- IV < 1 week → 800–1,600 mg oral daily 4
- IV 1–3 weeks → 600–800 mg oral daily 4
- IV > 3 weeks → 400 mg oral daily 4
These transition doses account for amiodarone's complex pharmacokinetics, including its large volume of distribution and extremely long half-life (14–58 days after chronic therapy) 5, 6. The transition doses are initially higher to maintain therapeutic tissue levels, then should be tapered to the standard maintenance range of 200–400 mg daily 1.
Critical Monitoring Considerations
- Thyroid function requires long-term surveillance even after amiodarone discontinuation, as thyroid dysfunction can occur months to years after stopping the drug due to prolonged tissue iodine load 7
- Pulmonary, hepatic, neurologic, and ocular monitoring is essential during maintenance therapy 1, 8
- Drug interactions are significant: amiodarone increases digoxin levels (requiring digoxin dose reduction to as low as 0.0625 mg daily in some patients), doubles warfarin effect, and interacts with statins and many other medications 1, 9, 8
Common Pitfalls
- Avoid maintaining patients on loading doses long-term—the 800–1,600 mg daily range is only for initial loading and should be reduced to 200–400 mg daily for maintenance 1
- Do not assume "low-dose" means no toxicity—even 200–400 mg daily carries substantial risk of adverse effects requiring discontinuation in approximately 22.9% of patients versus 15.4% on placebo 2
- Do not stop monitoring after drug discontinuation—amiodarone's effects persist for weeks to months due to its extraordinarily long half-life 5, 7